3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Urothelial Cancer
1
Synovitis, Pigmented Villonodular
1
Solid Tumor
1
Skin Neoplasms
1
Rectal Neoplasms
1
Polyps
1
Patient Satisfaction
1
Pancreatitis
1
Pancreatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Glioma
1
Diverticulosis, Colonic
1
Choledocholithiasis
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Carcinoma
1
Brain Neoplasms
1
Brain Diseases
1
Anxiety Disorders
1
Interventions
Doxorubicin
6
pazopanib
5
Trabectedin
4
Radiotherapy
3
temsirolimus
2
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Ifosfamide
2
Dexamethasone
2
sitravatinib
1
selinexor
1
saracatinib
1
romidepsin
1
regorafenib
1
plitidepsin
1
pembrolizumab
1
palbociclib
1
olaratumab
1
milademetan
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
efatutazone
1
cixutumumab
1
brigimadlin
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liposarcoma
×
Midazolam
×
Clear all
No trials found.